Warning Letter Roundup: FDA Warns Five Firms for Quality Deficiencies

Drug GMP Report
The FDA issued warnings to the following facilities in Australia, Korea, the European Union and the United States for deficiencies in records, documentation, GMPs, testing and validation:

To View This Article:


Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00